Hematology

Top Story

FDA grants priority review to crizanlizumab for pain crises in sickle cell disease

July 16, 2019
Meeting News

ASH announces award recipients

July 15, 2019
Several distinguished leaders in hematology will be honored with awards and special lectures at this year’s ASH Annual Meeting and Exposition, scheduled for Dec…
Advanced Practice

Integrating transition from pediatric- to adult-centered care: The APP’s role

HemOnc Today, July 10, 2019
Anne Nord, MSN, RN, FNP-C; Deborah G. Harris, MN, RN, CPNP-AC/PC, CPHON®; Susan M. Carson, MSN, RN, CPNP-PC; Trish Peterson, MSN, RN, CPNP-PC
Levon — an 18-year-old with sickle cell disease — enters the clinic room with his mom, who nervously allows him to proceed alone. “Welcome to…
In the Journals

Vena cava filters after major trauma fail to reduce incidence of pulmonary embolism, death

July 8, 2019
Placing an inferior vena cava filter in patients within 72 hours of major trauma did not reduce incidence of symptomatic pulmonary embolism or death at 90 days…
More Headlines »
CME

Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision Making – Rapid Response From Amsterdam

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Video

VIDEO: Array of FDA myeloma drug approvals, new research steer field in filling ‘unmet medical need’

June 2, 2016
More »
Resource Centers
CME

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »